Diana Ivanova

Prof. Diana Ivanova is a full-time faculty member at the Faculty of Pharmacy, Medical University "Prof. Dr. Paraskev Stoyanov" - Varna, where she holds the Professor rank in the Department of Biochemistry, Molecular Medicine and Nutrigenomics. She has contributed to over 150 scientific publications and supervised numerous PhD students in nutrigenomics and clinical biochemistry.

• Education: Master in Molecular Biology (Biochemistry) from Sofia University (1985), Master in Health Management from Medical University of Varna (2013)
• Academic Titles: Doctor (PhD) in Cell Biology/Plant Physiology (Moscow State University, 1990), Associate Professor (2007), Professor (2013), Doctor of Science (DSc) in Biological Sciences (2013)

Research Interests: Focus on oxidative status in physiological/pathological conditions, antioxidant protection mechanisms, nutrigenomics, metabolic adaptation, and biochemistry of nutrition-related diseases. Her work connects molecular biology with clinical applications through projects like MUVE-TEAM and international collaborations with institutions in Poland, Sweden, and the Netherlands.

Scientific Trends: Recent publications span colorectal cancer biomarkers, metabolic syndrome interventions, oral health diagnostics, burn wound healing, and functional food analysis. Common keywords include oxidative stress, gene expression, nutritional epidemiology, and biochemical diagnostics.

Awards:

• 2023 Union of Scientists - Varna Award
• 2023 Dean of Faculty of Pharmacy Award
• 2012 Honorary Badge with Blue Ribbon

Grants & Projects: Coordinator for projects like "Molecular mechanisms of cytodeox" (2022-2026), "Genetic biomarkers in colorectal carcinoma" (2024-2025), and EU-funded initiatives including NutriTech and MUVE-TEAM. She leads initiatives in health management and curriculum modernization.

Labs & Teams: Head of the Nutrigenomics Center at Medical University Varna, collaborating with European institutions like University of Wageningen (Netherlands) and Medical University of Silesia (Poland). She manages research teams in projects such as "Adipose Tissue: Key Target for Metabolic Syndrome" and "Cyanoprokaryotes and Cancer Risk".